Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cue Biopharma, Inc. (CUE) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cue Biopharma, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1645460.
Total stock buying since 2017: $5,880,051.
Total stock sales since 2017: $4,439,547.
Total stock option exercises since 2017: $746,930.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 30,000 | $30,900 | 0 | $0 | 0 | $0 |
| 2023 | 7,000 | $19,620 | 9,325 | $30,585 | 9,682 | $27,690 |
| 2022 | 968,000 | $4,315,300 | 0 | $0 | 98,335 | $0 |
| 2021 | 6,120 | $91,030 | 103,140 | $1,639,531 | 218,141 | $519,715 |
| 2020 | 24,048 | $421,323 | 26,900 | $538,132 | 83,565 | $199,525 |
| 2019 | 21,315 | $163,355 | 135,479 | $2,231,299 | 33,333 | $0 |
| 2018 | 166,202 | $823,523 | 0 | $0 | 0 | $0 |
| 2017 | 2,000 | $15,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-12 | 30,000 | $30,900 | 0 | $0 | 0 | $0 |
| 2023-08 | 7,000 | $19,620 | 0 | $0 | 0 | $0 |
| 2023-03 | 0 | $0 | 9,325 | $30,585 | 9,682 | $27,690 |
| 2022-08 | 0 | $0 | 0 | $0 | 6,667 | $0 |
| 2022-05 | 233,000 | $816,700 | 0 | $0 | 0 | $0 |
| 2022-03 | 735,000 | $3,498,600 | 0 | $0 | 91,668 | $0 |
| 2021-11 | 0 | $0 | 48,176 | $807,449 | 48,176 | $252,182 |
| 2021-10 | 0 | $0 | 1,251 | $17,782 | 34,585 | $9,382 |
| 2021-09 | 3,400 | $50,051 | 20,000 | $304,640 | 95,000 | $128,400 |
| 2021-08 | 0 | $0 | 0 | $0 | 6,667 | $0 |
| 2021-03 | 0 | $0 | 13,439 | $202,899 | 13,439 | $67,195 |
| 2021-02 | 0 | $0 | 20,274 | $306,761 | 20,274 | $62,556 |
| 2021-01 | 2,720 | $40,979 | 0 | $0 | 0 | $0 |
| 2020-11 | 6,548 | $82,773 | 0 | $0 | 0 | $0 |
| 2020-10 | 0 | $0 | 0 | $0 | 33,333 | $0 |
| 2020-09 | 10,000 | $151,500 | 0 | $0 | 0 | $0 |
| 2020-08 | 0 | $0 | 26,900 | $538,132 | 33,566 | $199,525 |
| 2020-06 | 7,500 | $187,050 | 0 | $0 | 0 | $0 |
| 2020-03 | 0 | $0 | 0 | $0 | 16,666 | $0 |
| 2019-12 | 0 | $0 | 135,479 | $2,231,299 | 0 | $0 |
| 2019-11 | 0 | $0 | 0 | $0 | 33,333 | $0 |
| 2019-06 | 21,315 | $163,355 | 0 | $0 | 0 | $0 |
| 2018-12 | 157,602 | $747,381 | 0 | $0 | 0 | $0 |
| 2018-08 | 7,000 | $56,990 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-12-16 | Passeri Daniel R (CHIEF EXECUTIVE OFFICER) | Buy | 30,000 | 1.03 | 30,900 |
| 2023-08-25 | Suri Anish (PRESIDENT AND CSO) | Buy | 4,000 | 2.76 | 11,040 |
| 2023-08-14 | Passeri Daniel R (CHIEF EXECUTIVE OFFICER) | Buy | 3,000 | 2.86 | 8,580 |
| 2023-03-23 | Kiener Peter A (Director) | Sale | 9,325 | 3.28 | 30,585 |
| 2023-03-23 | Kiener Peter A (Director) | Option Ex | 9,682 | 2.86 | 27,690 |
| 2022-08-21 | Millar Kerri-ann (CHIEF FINANCIAL OFFICER) | Option Ex | 6,667 | .00 | 0 |
| 2022-05-27 | Morich Frank (Director) | Buy | 28,000 | 3.75 | 105,000 |
| 2022-05-24 | Fletcher Aaron G.l. (Director) | Buy | 55,000 | 3.34 | 183,700 |
| 2022-05-23 | Fletcher Aaron G.l. (Director) | Buy | 150,000 | 3.52 | 528,000 |
| 2022-03-31 | Fletcher Aaron G.l. (Director) | Buy | 735,000 | 4.76 | 3,498,600 |
| 2022-03-31 | Suri Anish (PRESIDENT AND CSO) | Option Ex | 16,668 | .00 | 0 |
| 2022-03-31 | Passeri Daniel R (CHIEF EXECUTIVE OFFICER) | Option Ex | 75,000 | .00 | 0 |
| 2021-11-16 | Kiener Peter A (Director) | Sale | 1,361 | 18.02 | 24,525 |
| 2021-11-16 | Kiener Peter A (Director) | Option Ex | 1,361 | 2.86 | 3,892 |
| 2021-11-15 | Suri Anish (President and CSO) | Sale | 8,000 | 18.05 | 144,400 |
| 2021-11-15 | Suri Anish (President and CSO) | Option Ex | 8,000 | 8.26 | 66,080 |
| 2021-11-15 | Kiener Peter A (Director) | Sale | 18,815 | 17.92 | 337,164 |
| 2021-11-15 | Kiener Peter A (Director) | Option Ex | 18,815 | 2.86 | 53,810 |
| 2021-11-11 | Suri Anish (President and CSO) | Sale | 20,000 | 15.07 | 301,360 |
| 2021-11-11 | Suri Anish (President and CSO) | Option Ex | 20,000 | 6.42 | 128,400 |
| 2021-10-03 | Suri Anish (PRESIDENT AND CSO) | Option Ex | 33,334 | .00 | 0 |
| 2021-10-01 | Millar Kerri-ann (CHIEF FINANCIAL OFFICER) | Sale | 1,251 | 14.21 | 17,782 |
| 2021-10-01 | Millar Kerri-ann (CHIEF FINANCIAL OFFICER) | Option Ex | 1,251 | 7.50 | 9,382 |
| 2021-09-30 | Passeri Daniel R (CHIEF EXECUTIVE OFFICER) | Option Ex | 75,000 | .00 | 0 |
| 2021-09-24 | Passeri Daniel R (CHIEF EXECUTIVE OFFICER) | Buy | 3,400 | 14.72 | 50,051 |
| 2021-09-23 | Suri Anish (PRESIDENT AND CSO) | Sale | 20,000 | 15.23 | 304,640 |
| 2021-09-23 | Suri Anish (PRESIDENT AND CSO) | Option Ex | 20,000 | 6.42 | 128,400 |
| 2021-08-23 | Millar Kerri-ann (CHIEF FINANCIAL OFFICER) | Option Ex | 6,667 | .00 | 0 |
| 2021-03-16 | Pienta Kenneth (Chief Medical Officer) | Sale | 439 | 15.09 | 6,625 |
| 2021-03-16 | Pienta Kenneth (Chief Medical Officer) | Option Ex | 439 | 5.00 | 2,195 |
| 2021-03-15 | Pienta Kenneth (Chief Medical Officer) | Sale | 13,000 | 15.10 | 196,274 |
| 2021-03-15 | Pienta Kenneth (Chief Medical Officer) | Option Ex | 13,000 | 5.00 | 65,000 |
| 2021-02-17 | Pienta Kenneth (Chief Medical Officer) | Sale | 4,274 | 15.05 | 64,345 |
| 2021-02-17 | Pienta Kenneth (Chief Medical Officer) | Option Ex | 4,274 | 3.93 | 16,796 |
| 2021-02-16 | Pienta Kenneth (Chief Medical Officer) | Sale | 16,000 | 15.15 | 242,416 |
| 2021-02-16 | Pienta Kenneth (Chief Medical Officer) | Option Ex | 16,000 | 2.86 | 45,760 |
| 2021-01-20 | Pienta Kenneth (Chief Medical Officer) | Buy | 2,720 | 15.07 | 40,979 |
| 2020-11-24 | Fletcher Aaron G.l. (Director) | Buy | 6,548 | 12.64 | 82,773 |
| 2020-10-03 | Suri Anish (President and CSO) | Option Ex | 33,333 | .00 | 0 |
| 2020-09-30 | Gray Cameron (Director) | Buy | 5,000 | 15.30 | 76,500 |
| 2020-09-29 | Gray Cameron (Director) | Buy | 5,000 | 15.00 | 75,000 |
| 2020-08-21 | Millar Kerri-ann (CFO) | Option Ex | 6,666 | .00 | 0 |
| 2020-08-05 | Suri Anish (President and CSO) | Sale | 800 | 20.01 | 16,008 |
| 2020-08-05 | Suri Anish (President and CSO) | Option Ex | 800 | 6.42 | 5,136 |
| 2020-08-05 | Sandercock Colin (SVP, General Counsel and Sec) | Sale | 13,274 | 20.00 | 265,480 |
| 2020-08-05 | Sandercock Colin (SVP, General Counsel and Sec) | Option Ex | 13,274 | 7.50 | 99,555 |
| 2020-08-04 | Suri Anish (President and CSO) | Sale | 400 | 20.14 | 8,056 |
| 2020-08-04 | Suri Anish (President and CSO) | Option Ex | 400 | 6.42 | 2,568 |
| 2020-08-04 | Sandercock Colin (SVP, General Counsel and Sec) | Sale | 201 | 20.05 | 4,030 |
| 2020-08-04 | Sandercock Colin (SVP, General Counsel and Sec) | Option Ex | 201 | 7.50 | 1,507 |
| 2020-08-03 | Suri Anish (President and CSO) | Sale | 5,800 | 20.01 | 116,058 |
| 2020-08-03 | Suri Anish (President and CSO) | Option Ex | 5,800 | 7.34 | 42,572 |
| 2020-08-03 | Sandercock Colin (SVP, General Counsel and Sec) | Sale | 6,425 | 20.00 | 128,500 |
| 2020-08-03 | Sandercock Colin (SVP, General Counsel and Sec) | Option Ex | 6,425 | 7.50 | 48,187 |
| 2020-06-24 | Fletcher Aaron G.l. (Director) | Buy | 7,500 | 24.94 | 187,050 |
| 2020-03-31 | Suri Anish (President and CSO) | Option Ex | 16,666 | .00 | 0 |
| 2019-12-31 | Marlett Christopher A (Director) | Sale | 31,400 | 15.74 | 494,236 |
| 2019-12-27 | Marlett Christopher A (Director) | Sale | 18,000 | 17.24 | 310,320 |
| 2019-12-26 | Marlett Christopher A (Director) | Sale | 19,647 | 17.53 | 344,411 |
| 2019-12-23 | Marlett Christopher A (Director) | Sale | 17,000 | 16.82 | 285,940 |
| 2019-12-19 | Marlett Christopher A (Director) | Sale | 4,000 | 17.00 | 68,000 |
| 2019-12-17 | Marlett Christopher A (Director) | Sale | 20,732 | 15.73 | 326,114 |
| 2019-11-01 | Suri Anish (President and CSO) | Option Ex | 33,333 | .00 | 0 |
| 2019-06-21 | Passeri Daniel R (CEO and President) | Buy | 1,377 | 7.26 | 9,997 |
| 2019-06-10 | Sandercock Colin (SVP, General Counsel and Sec) | Buy | 14,938 | 7.93 | 118,458 |
| 2019-06-06 | Sandercock Colin (SVP, General Counsel and Sec) | Buy | 2,000 | 7.10 | 14,200 |
| 2019-06-06 | Passeri Daniel R (CEO and President) | Buy | 3,000 | 6.90 | 20,700 |
| 2018-12-31 | Marlett Christopher A (Director) | Buy | 18,521 | 4.64 | 85,937 |
| 2018-12-28 | Digiandomenico Anthony (Director) | Buy | 7,000 | 4.62 | 32,340 |
| 2018-12-27 | Digiandomenico Anthony (Director) | Buy | 20,000 | 4.77 | 95,399 |
| 2018-12-26 | Marlett Christopher A (Director) | Buy | 19,647 | 4.29 | 84,285 |
| 2018-12-24 | Digiandomenico Anthony (Director) | Buy | 10,000 | 4.81 | 48,099 |
| 2018-12-21 | Suri Anish (Chief Scientific Officer) | Buy | 2,000 | 4.37 | 8,740 |
| 2018-12-21 | Digiandomenico Anthony (Director) | Buy | 10,000 | 4.49 | 44,900 |
| 2018-12-21 | Marlett Christopher A (Director) | Buy | 17,200 | 4.53 | 77,916 |
| 2018-12-20 | Marlett Christopher A (Director) | Buy | 9,438 | 4.74 | 44,736 |
| 2018-12-19 | Marlett Christopher A (Director) | Buy | 400 | 5.00 | 2,000 |
| 2018-12-18 | Marlett Christopher A (Director) | Buy | 3,664 | 5.20 | 19,052 |
| 2018-12-17 | Digiandomenico Anthony (Director) | Buy | 10,000 | 5.48 | 54,800 |
| 2018-12-13 | Marlett Christopher A (Director) | Buy | 10,000 | 5.06 | 50,599 |
| 2018-12-12 | Marlett Christopher A (Director) | Buy | 12,189 | 5.08 | 61,920 |
| 2018-12-11 | Marlett Christopher A (Director) | Buy | 7,543 | 4.86 | 36,658 |
| 2018-08-29 | Millar Kerri-ann (VP-Finance) | Buy | 1,000 | 8.48 | 8,480 |
| 2018-08-16 | Passeri Daniel R (CEO and President) | Buy | 6,000 | 8.09 | 48,510 |
| 2018-06-29 | Passeri Daniel R (CEO and President) | Buy | 1,600 | 11.97 | 19,152 |
| 2017-12-27 | Pienta Kenneth (Chief Medical Officer) | Buy | 2,000 | 7.50 | 15,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of CUE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cue Biopharma, Inc. (symbol CUE, CIK number 1645460) see the Securities and Exchange Commission (SEC) website.